Healthcare Services
Search documents
NRC Health Honors 2025 Leaders in Patient Experience and Loyalty
Businesswire· 2025-10-15 10:45
Core Insights - NRC Health has announced the recipients of its 2025 healthcare experience awards program, highlighting excellence in the healthcare sector [1] Group 1 - The awards program recognizes organizations that have demonstrated outstanding performance in healthcare experience [1] - NRC Health aims to promote best practices and innovations in the healthcare industry through these awards [1]
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Molina Healthcare, Inc. of Class Action Lawsuit and Upcoming Deadlines – MOH
Globenewswire· 2025-10-14 22:00
Core Viewpoint - A class action lawsuit has been filed against Molina Healthcare, Inc. regarding allegations of securities fraud and unlawful business practices [2][4]. Financial Performance - On July 7, 2025, Molina reported second quarter adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures across all business lines [4]. - Molina cut its full year 2025 adjusted earnings per share guidance by 10.2% at the midpoint, revising it from at least $24.50 per share to a range of $21.50 to $22.50 per share [4]. - Following this announcement, Molina's stock price fell by $6.97 per share, or 2.9%, closing at $232.61 per share [4]. Subsequent Guidance Adjustments - On July 23, 2025, Molina further reduced its full-year 2025 earnings guidance, now expecting adjusted earnings to be no less than $19.00 per diluted share, representing a 13.6% cut from the previous guidance [5]. - The company's GAAP net income for the second quarter was reported at $4.75 per diluted share, an 8% decrease year over year [5]. - Molina also cut its full year 2025 GAAP net income guidance by 27% to $912 million, attributing the results to a challenging medical cost trend environment [5]. - Following this news, Molina's stock price dropped by $32.03 per share, or 16.84%, closing at $158.22 per share [5].
Wall Street Analysts Predict a 36.47% Upside in Select Medical (SEM): Here's What You Should Know
ZACKS· 2025-10-14 14:56
Core Viewpoint - Select Medical (SEM) shares have increased by 7.8% in the past four weeks, closing at $13.19, with a mean price target of $18 indicating a potential upside of 36.5% [1] Price Targets and Analyst Estimates - The mean estimate consists of six short-term price targets with a standard deviation of $2.9, where the lowest estimate is $14.00 (6.1% increase) and the highest is $21.00 (59.2% increase) [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Sentiment - Analysts are optimistic about SEM's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which has shown a strong correlation with stock price movements [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 1.1%, with one estimate moving higher and no negative revisions [12] Zacks Rank and Investment Potential - SEM holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting the extent of gains, they can provide a directional guide for potential price movement [14]
S&P 500 Yesterday: Biggest Winners BBY, AVGO And Losers FAST, LVS
Forbes· 2025-10-14 14:00
Market Performance - On October 13, stocks experienced a significant increase, with the S&P 500 rising by 1.56%, the Dow 30 by 1.29%, and the Nasdaq 100 by 2.18% [2] - Over the past week, the S&P 500 fell by 1.27%, the Dow 30 by 1.34%, and the Nasdaq 100 by 0.91%, indicating a broad pullback despite some resilient stocks [5] - In the last month, the S&P 500 increased by 1.07%, the Dow 30 by 0.51%, and the Nasdaq 100 by 2.73%, showing a positive trend overall [7] Stock Performance - A list of the top 10 S&P 500 winners and losers was provided, highlighting significant stock movements that warrant attention [3][7] - Humana (HUM) is noted as attractive, while Broadcom (AVGO) is described as attractive but volatile, suggesting potential investment opportunities [3] Investment Strategy - The Trefis High Quality Portfolio is emphasized as a diversified approach, suggesting a mix of 10% commodities, 10% gold, and 2% crypto alongside equities and bonds for better returns and protection against market downturns [4] - The HQ Portfolio, consisting of 30 stocks, has a track record of outperforming benchmarks like the S&P 500, S&P mid-cap, and Russell 2000 indices, providing better returns with less risk [8]
Children's Hospital Los Angeles Taps Oracle to Enhance Business Systems
Prnewswire· 2025-10-14 12:02
Core Insights - Children's Hospital Los Angeles (CHLA) has improved the performance of its mission-critical business systems by up to 98% using Oracle Autonomous AI Database on Oracle Cloud Infrastructure (OCI) [1][2] - CHLA is transitioning its finance, HR, supply chain, and customer experience processes to Oracle Fusion Cloud Applications to enhance efficiency and support growth [1][2] Company Overview - CHLA is ranked among the top 10 pediatric hospitals in the U.S., employing nearly 8,000 staff and conducting over 16,000 surgeries and 747,000 patient visits annually [2] - The hospital previously utilized Oracle Base Database Service on OCI for its PeopleSoft enterprise resource planning and human capital management applications [2] Technology Implementation - CHLA selected Oracle Autonomous AI Database to support its business systems, aiming for improved data security, performance, and availability [2][3] - The migration to Oracle Autonomous AI Database is part of CHLA's cloud modernization strategy, focusing on enhancing user experience and optimizing resource usage [3] Future Plans - CHLA plans to implement Oracle Fusion Cloud ERP to automate financial management, Oracle Fusion Cloud HCM to enhance employee experience, and Oracle Fusion Cloud SCM to improve supply chain efficiency [4] - The integration of Oracle Fusion Cloud Customer Experience will enable more personalized engagement, enhancing service and patient experience [4] Support and Services - Oracle Customer Success Services is assisting CHLA with its migration and provides full lifecycle management, including system upgrades and disaster recovery [3] - This support helps protect critical business data and maintain regulatory compliance across CHLA's core systems [3]
CommonSpirit names new CFO
Yahoo Finance· 2025-10-14 09:28
Core Insights - Michael Browning has been appointed as the new Senior Executive Vice President and Chief Financial Officer of CommonSpirit Health, effective January 2, 2026, succeeding Daniel Morissette who is retiring [1][3]. Group 1: Leadership Transition - Browning will oversee financial operations for CommonSpirit Health's portfolio of 138 hospitals, focusing on financial strategy, planning, accounting, treasury, reimbursement, revenue cycle, and investor relations [2]. - He previously served as Executive Vice President and CFO at OhioHealth and has held leadership roles at ProMedica Health System, WakeMed Health & Hospitals, Parkview Health, and McLeod Health [2]. Group 2: Financial Strategy and Challenges - CommonSpirit Health is looking to improve its financial performance after experiencing years of operating losses [4]. - The organization has initiated Project Impact, a multiyear initiative aimed at reducing expenses and exploring innovative revenue growth opportunities [4].
X @The Wall Street Journal
The Wall Street Journal· 2025-10-14 03:16
Hospitals are training more high-school students to work in healthcare fields https://t.co/RdoWO6VUiI ...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Molina Healthcare, Inc. of Class Action Lawsuit and Upcoming Deadlines - MOH
Prnewswire· 2025-10-13 17:42
Core Viewpoint - A class action lawsuit has been filed against Molina Healthcare, Inc. regarding allegations of securities fraud and unlawful business practices [1][2]. Financial Performance - On July 7, 2025, Molina reported second quarter adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures across all business lines [2]. - The company cut its full-year 2025 adjusted earnings per share guidance by 10.2% at the midpoint, revising it from at least $24.50 per share to a range of $21.50 to $22.50 per share [2]. - Molina's stock price fell by $6.97 per share, or 2.9%, closing at $232.61 on July 7, 2025, following the earnings announcement [2]. - On July 23, 2025, Molina further reduced its full-year 2025 earnings guidance, now expecting adjusted earnings to be no less than $19.00 per diluted share, representing a 13.6% cut from the previous guidance [2]. - The company's GAAP net income for the second quarter was reported at $4.75 per diluted share, an 8% decrease year over year [2]. - Molina also cut its full-year 2025 GAAP net income guidance by 27% to $912 million, attributing the results to a challenging medical cost trend environment [2]. - Following this announcement, Molina's stock price dropped by $32.03 per share, or 16.84%, closing at $158.22 on July 24, 2025 [2].
Here's Why Cardinal Health (CAH) is a Strong Growth Stock
ZACKS· 2025-10-13 14:45
Core Insights - Zacks Premium provides various tools for investors to enhance their stock market strategies, including daily updates, research reports, and stock screens [1][2] Company Overview - Cardinal Health is a leading global healthcare services and products provider, serving nearly 90% of U.S. hospitals and managing over 43,000 pharmaceutical shipments daily [11] - The company operates in multiple segments, including Pharmaceutical & Specialty Solutions and Global Medical Products & Distribution, and offers a wide range of medical and surgical products [11] Investment Ratings - Cardinal Health holds a 2 (Buy) rating on the Zacks Rank, indicating strong potential for investment [12] - The company has a VGM Score of A, suggesting it is an attractive option for investors [12] Growth Potential - Cardinal Health is projected to achieve a year-over-year earnings growth of 14.3% for the current fiscal year, supported by upward revisions in earnings estimates from analysts [12] - The Zacks Consensus Estimate for Cardinal Health's earnings has increased by $0.21 to $9.42 per share [12] Performance Metrics - Cardinal Health has demonstrated an average earnings surprise of +9.2%, indicating a history of exceeding earnings expectations [12] - The combination of a solid Zacks Rank and high Growth and VGM Style Scores positions Cardinal Health as a strong candidate for investors [13]
Baptist Hospital Enhances Patient Safety and Air Quality with Good Salt(TM) Life's ByoCart(TM) Disinfection System
Accessnewswire· 2025-10-13 12:30
ATHENS, GA / ACCESS Newswire / October 13, 2025 / NDT Pharmaceuticals Inc. (OTC PINK:NDTP), a leader in health and wellness solutions, today announced that its wholly owned subsidiary, Good Saltâ"¢ Life, Inc., has deployed its advanced ByoCartâ"¢ Disinfection System at Baptist Hospital, the flagship facility of Baptist Health. The ByoCart system will enhance Baptist Hospital's infection prevention and environmental safety protocols by improving both surface disinfection and air quality throughout patient ca ...